Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Antimicrobial Susceptibility Patterns Among Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Large Pediatric Hospital in the United Kingdom.

Drew RJ., Ormandy EE., Ball K., Lambert SE., Paulus S., Williams NJ., Cunliffe NA.

Of the 551 extended spectrum β-lactamase-producing isolates characterized, the MIC90 for Escherichia coli, Klebsiella spp., and Enterobacter spp. were in the susceptible range when tested against meropenem, but were in the resistant range for all other antimicrobials tested excluding E coli and Klebsiella spp. against ertapenem and ciprofloxacin, and for Enterobacter spp. against ciprofloxacin.

More information Original publication

DOI

10.1093/jpids/piu094

Type

Journal article

Publication Date

2015-12-01T00:00:00+00:00

Volume

4

Pages

e147 - e150

Keywords

E coli, ESBL, antimicrobial resistance, extended spectrum β-lactamase, meropenem, Anti-Bacterial Agents, Child, Drug Resistance, Bacterial, Enterobacteriaceae, Escherichia coli, Hospitals, Pediatric, Humans, Klebsiella, Microbial Sensitivity Tests, United Kingdom, beta-Lactamases